Kenner C. Rice, Ph.D., Senior Investigator - Principal Investigators - The Intramural Research Program of the National Institute on Drug Abuse

Skip Navigation

PRINCIPAL INVESTIGATORS

Kenner C. Rice, Ph.D., Senior Investigator

CONTACT ME

NIDA IRP
9800 Medical Center Drive
Rm 228A, MSC-3373
Bethesda, MD 20892

Phone: 301-217-5200
Fax: 301-217-5214

kennerr@mail.nih.gov

Kenner C. Rice, Ph.D., Senior Investigator

Chief, Chemical Biology Research Branch (CBRB)
Chief, Drug Design and Synthesis Section (DDSS)

Post-doctoral Training - Section on Medicinal Chemistry, National Institute on Diabetes and Digestive and Kidney Disease, National Institutes of Health; Advisor: Everette L. May

Ph.D. - Organic Chemistry, Georgia Institute of Technology; Advisor: Dr. John R. Dyer

B.S. - Chemistry, Virginia Military Institute

RESEARCH INTERESTS

Our major research direction is the elucidation of the structure and function of neurotransmitter systems in the mammalian central nervous system (CNS) in normal, drug-altered, and pathological states and the molecular mechanism of action of CNS active drugs. Organic/medicinal chemistry is the foundation of the multidisciplinary approach utilized in these studies that requires the rational design and chemical synthesis of novel agonists, antagonists, imaging agents, affinity ligands, and other drugs for particular applications. Our principal focus is the application of these techniques to study the mechanism of action of abused drugs and the development of medications for the treatment and prevention of drug abuse. Our present research areas are: (1) opioid receptor subtypes, (2) cocaine and other psychomotor stimulants, (3) cannabinoid (marijuana) receptors, (4) the role of corticotropin releasing hormone receptors in the regulation of the hypothalamic-pituitary-adrenal axis coordinating neuroendocrine, autonomic, immune, and behavioral responses to stress, and (5) development of new ligands for PET and SPECT imaging of drug receptors in the CNS of living animals and conscious humans. The multidisciplinary nature of this program requires extensive collaboration with other groups with diverse pharmacological and biological expertise from within and outside of NIH. These studies also require multistep chemical synthesis of gram and larger quantities of target compounds. Our program has provided potential medications, many new research tools, and much valuable technology for drug abuse research. The latter includes the development of the NIH Opiate Total Synthesis that offers synthetic production of both enantiomers of medical opiates and their antagonists and thus independence from foreign sources of opium.

Selected Publications:

View more publications at PubMed.

More about Dr. Rice

Health and Human Services Logo National Institute on Drug Abuse Logo


The National Institute on Drug Abuse (NIDA), is part of the National Institutes of Health (NIH), the principal biomedical and behavioral research agency of the United States Government. NIH is a component of the U.S. Department of Health and Human Services.

PDF documents require the free Adobe Reader. Microsoft Word documents require the free Microsoft Word viewer. Microsoft PowerPoint documents require the free Microsoft PowerPoint viewer. Flash content requires the free Adobe Flash Player.